| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Solasia Pharma K.K (F: 9SO)
9SO Technical Analysis
5
| As on 8th Jan 2026 9SO STOCK Price closed @ 0.14 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.20 & Strong Sell for SHORT-TERM with Stoploss of 0.23 we also expect STOCK to react on Following IMPORTANT LEVELS. |
9SOSTOCK Price
| Open | 0.14 | Change | Price | % |
| High | 0.14 | 1 Day | -0.04 | -22.22 |
| Low | 0.14 | 1 Week | 0.00 | 0.00 |
| Close | 0.14 | 1 Month | -0.01 | -6.67 |
| Volume | 100 | 1 Year | -0.19 | -57.58 |
| 52 Week High 0.33 | 52 Week Low 0.13 | ||||
F Germany Most Active Stocks
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| BN5 | 0.00 | % |
| BN5 | 0.00 | % |
| WHL | 5150.00 | -0.44% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| 9SO Daily Charts |
9SO Intraday Charts |
Whats New @ Bazaartrend |
9SO Free Analysis |
|
|
9SO Important Levels Intraday
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
9SO Forecast January 2026
| 4th UP Forecast | 0.27 |
| 3rd UP Forecast | 0.23 |
| 2nd UP Forecast | 0.2 |
| 1st UP Forecast | 0.18 |
| 1st DOWN Forecast | 0.1 |
| 2nd DOWN Forecast | 0.08 |
| 3rd DOWN Forecast | 0.05 |
| 4th DOWN Forecast | 0.01 |
9SO Weekly Forecast
| 4th UP Forecast | 0.18 |
| 3rd UP Forecast | 0.17 |
| 2nd UP Forecast | 0.16 |
| 1st UP Forecast | 0.15 |
| 1st DOWN Forecast | 0.13 |
| 2nd DOWN Forecast | 0.12 |
| 3rd DOWN Forecast | 0.11 |
| 4th DOWN Forecast | 0.10 |
9SO Forecast2026
| 4th UP Forecast | 0.53 |
| 3rd UP Forecast | 0.4 |
| 2nd UP Forecast | 0.33 |
| 1st UP Forecast | 0.25 |
| 1st DOWN Forecast | 0.03 |
| 2nd DOWN Forecast | -0.05 |
| 3rd DOWN Forecast | -0.12 |
| 4th DOWN Forecast | -0.25 |
Solasia Pharma K.K ( F Germany Symbol : 9SO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
9SO Other Details
| Segment | EQ | |
| Market Capital | 112303960.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > echo $website ; ?> | |
9SO Address
![]() |
||
9SO Latest News
9SO Business Profile
Solasia Pharma K.K. develops and commercializes drugs in the field of oncology in Japan and other Asian countries. The company offers SP-03 (episil oral liquid) for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy for cancer; and SP-01 (Sancuso), a transdermal delivery system that delivers granisetron, an anti-emetic into the patient's bloodstream for the treatment of chemotherapy induced nausea and vomiting. It is also developing SP-02 (Darinaparsin), a mitochondrial-targeted agent that has completed phase III clinical study to treat various hematologic and solid cancers; and SP-04 (PledOx), an intracellular superoxide removing agent, which is in phase IIb clinical trials for chemotherapy induced peripheral neuropathy. In addition, the company is developing SP-05 (Arfolitixorin) that is in phase III clinical study for the enhancement of antitumor efficacy of fluorouracil, including the treatment for pancreatic cancer, breast cancer, stomach cancer, and head and neck cancers. Solasia Pharma K.K. was founded in 2006 and is based in Tokyo, Japan. Address: Sumitomo Fudosan Shiba-Koen Tower, Tokyo, Japan, 105-0011
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

